Microvascular obstruction due to thrombosis and fibrin deposition in myocardial infarction

Microvascular obstruction due to thrombosis and fibrin deposition in myocardial infarction

Objective: It is widely known that myocardial damage is not immediately terminated after the elimination of epicardial occlusion in cases of myocardial infarction. In situ thrombosis during epicardial occlusion might contribute to poor myocardial perfusion after reperfusion of an occluded epicardia...

Full description

Bibliographic Details
Main Authors:	Emre Aslanger, Seyhun Solakoğlu, Öner Doğan, Murat Sezer, Sabahattin Umman
Format:	Article
Language:	English
Published:	KARE Publishing 2016-02-01
Series:	Türk Kardiyoloji Derneği Arşivi
Subjects:	microvascular flow fibrin; myocardial infarction; no-reflow phenomenon; reperfusion injury.
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-39345

Similar Items

A fibrin targeted molecular imaging evaluation of microvascular no‐reflow in acute ischemic stroke
by: Xi Chen, et al.
Published: (2022-02-01)

The Role of Microvascular Obstruction and Intra-Myocardial Hemorrhage in Reperfusion Cardiac Injury. Analysis of Clinical Data
by: Vyacheslav V. Ryabov, et al.
Published: (2024-03-01)

Bimodal Pattern of Coronary Microvascular Involvement in Diabetes Mellitus
by: Murat Sezer, et al.
Published: (2016-10-01)

Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion
by: X.J. Zhao, et al.
Published: (2014-03-01)

Myocardial ischemia – reperfusion injury
by: S. V. Salo, et al.
Published: (2023-10-01)

Gradual Versus Abrupt Reperfusion During Primary Percutaneous Coronary Interventions in ST‐Segment–Elevation Myocardial Infarction (GUARD)
by: Murat Sezer, et al.
Published: (2022-05-01)

High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
by: Uygar Cagdas Yuksel, et al.
Published: (2011-01-01)

No-Reflow Phenomenon in Patients with ST-Elevation Acute Myocardial Infarction, Treated with Primary Percutaneous Coronary Intervention: A Study of Predictive Factors
by: Seyed Hashem Danesh Sani, et al.
Published: (2014-11-01)

The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of microvascular obstruction during primary percutaneous coronary intervention
by: Sheraz A Nazir, et al.
Published: (2016-12-01)

Growth Differentiation Factor 15 as a Predictor of the No-Reflow Phenomenon in Patients with ST-Segment Elevation Myocardial Infarction
by: Marcin Kożuch, et al.
Published: (2022-12-01)

Adenosine in Acute Myocardial Infarction-Associated Reperfusion Injury: Does it Still Have a Role?
by: Corrado De Marco, et al.
Published: (2022-05-01)

NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01)

Coronary Microvascular Injury in Reperfused Acute Myocardial Infarction: A View From an Integrative Perspective
by: Murat Sezer, et al.
Published: (2018-11-01)

No-reflow phenomenon and triglyceride-glucose index in acute myocardial infarction
by: Murat Kerkutluoglu, et al.
Published: (2023-08-01)

Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction
by: Mustafa Begenc Tascanov, et al.
Published: (2019-07-01)

Lactated Ringer's solution for preventing myocardial reperfusion injury
by: Takashi Koyama
Published: (2017-06-01)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
by: Mohammad Alidoosti, et al.
Published: (2018-07-01)

CORONARY MICROVASCULAR OBSTRUCTION PHENOMENON AFTER ENDOVASCULAR RECANALIZATION IN PATIENTS WITH CHRONIC CORONARY OCCLUSIONS
by: N. A. Yaitsky, et al.
Published: (2018-01-01)

Pathophysiological aspects and management workflow of coronary microvascular obstruction in ST-segment elevation myocardial infarction
by: Giancarla Scalone, et al.
Published: (2016-03-01)

Incidence and Associated Factors of No-reflow Phenomenon in STEMI Patients Treated with Primary PCI
by: Abdolatif Amini, et al.
Published: (2010-09-01)

Dilation of the Infarct-Related Coronary Artery to Reduce the Incidence of the No-Reflow Phenomenon in STEMI Patients
by: G. V. Sazanov, et al.
Published: (2023-08-01)

Microvascular Obstruction in Acute Myocardial Infarction, a Potential Therapeutic Target
by: Mina Ghobrial, et al.
Published: (2023-09-01)

Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention
by: Francesco Pelliccia, et al.
Published: (2023-12-01)

Aspiration Thrombectomy in Patients with Acute Myocardial Infarction—5-Year Analysis Based on a Large National Registry (ORPKI)
by: Rafał Januszek, et al.
Published: (2020-11-01)

Treatment Outcomes in STEMI Patients With No/Slow-Reflow Phenomenon, Depending on Age
by: G. V. Sazanov, et al.
Published: (2023-11-01)

Effect of no-reflow/reflow on P-wave time indexes in patients with acute myocardial infarction undergoing percutaneous coronary intervention
by: Ahmet Karakurt, et al.
Published: (2020-01-01)

No-reflow phenomenon after revascularization in acute ischemic stroke: Achilles' heel of the neurointerventionalist?
by: CHEN Kangning, et al.
Published: (2022-01-01)

No reflow phenomenon in CAD patients after percutaneous coronary intervention: A prospective hospital based observational study
by: Shivani Rao, et al.
Published: (2023-03-01)

Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention
by: Maryam Shakiba, et al.
Published: (2020-04-01)

Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention
by: Seifollah Abdi, et al.
Published: (2015-01-01)

The ‘MAP strategy’ (Maximum aspiration of atherothrombus and adjunctive glycoprotein IIb/IIIa inhibitor utilization combined with prolonged inflation of balloon/stent) for preventing no-reflow in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: A retrospective analysis of seventy-one cases
by: Anil Potdar, et al.
Published: (2015-12-01)

Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers
by: Hassan Shemirani, et al.
Published: (2014-01-01)

RDW as A Predictor for No-Reflow Phenomenon in DM Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Ying Sun, et al.
Published: (2023-01-01)

CMR of microvascular obstruction and hemorrhage in myocardial infarction
by: Wu Katherine C
Published: (2012-09-01)

A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon
by: Larisa Renata Pantea-Roșan, et al.
Published: (2022-04-01)

D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: asystematic review and metanalysis
by: Flavio Giuseppe Biccirè, et al.
Published: (2021-12-01)

Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Mohamed Khalfallah, et al.
Published: (2022-03-01)

Utility of electrocardiogram to predict the occurrence of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PPCI): a systematic review and meta-analysis
by: Elmira Jafari Afshar, et al.
Published: (2024-01-01)

Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention
by: Barış Yaylak, et al.
Published: (2018-12-01)

Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST‐Elevation Myocardial Infarction
by: Ayman Al‐Atta, et al.
Published: (2023-09-01)